The effect of subcutaneous methotrexate on markers of metabolic syndrome in psoriatic patients - preliminary report.

Postepy Dermatol Alergol · 2018 · PMC5872240 · PMID 29599672

Europe PMC DOI

hedged sentence

0.0522

closest p · 1.0× alpha

0.0522

boldest claim

The sentences

on the threshold of significancep = 0.0522so close (0.05 < p ≤ 0.1)

However, the correlation between PASI and TGF-β prior to treatment was on the threshold of significance ( p = 0.0522) and low after treatment ( p = 0.4977) ( Table 6 ).

also in 39 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.